Take 20% gains on Kahn Resources (KRI) and Cytori Therapeutics (CYTX)
Today's Financial News - Posted November 23, 2009
We’ve hit are targeted profits on these two free TFN recommendations. Bank those gains!
By Laura Cadden, TodaysFinancialNews.com
Baltimore (TFN): Just last Thursday, I asked readers who got in at our buy price of $3.71 for Cytori Therapeutics (NASDAQ:CYTX) to lock in a minimum of 10% gains with a wealth protection stop-loss. After all, in these markets you just can’t be too sure.
But the news of the clinical trial for its RESTORE 2 (read more about that here) has given us the momentum we needed to bank a sweet 20% gain.
Kahn Resources Inc. (TSE:KRI) has also happily hit that 20% mark today.
We first told TFN readers about this highly-speculative play on Oct. 1 (read that article here).
The Canadian uranium miner has gone up over 20% in just 34 trading days rewarding those brave penny stock investors that got in on our recommendation with some quick gains.
Take ‘em home and enjoy!
Next Article: Which sector will benefit the most from today’s data?
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down